January 2013 FDA Recall Drug by Mission Pharmacal Co
D-602-2013 - Superpotent

This Class III drug recall was voluntarily initiated by Mission Pharmacal Co on January 23, 2013 for the product Drug. The FDA reported the reason for recall as superpotent. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-602-2013

Reason for Recall
Superpotent: Drug product active ingredients were formulated incorrectly (too high) with respect to the label strength.
Initiated
01-23-2013
Reported
06-26-2013
Quantity
8,437 bottles

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
64149
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Mission Pharmacal Co
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide
Termination Date About Termination Date
Date that FDA officially terminated the recall.
03-18-2014
Product Description About Product Description
Full technical description of the product.
Sodium Sulfacetamide 10% and Sulfur 5% Lotion, (NDC 42792-102-01), 25 g Manufactured for: Austin Pharmaceuticals, LLC, Wilmington, DE

Batch or Lot Expiration Information

Lot# E112, Exp 05/14
Lot# J062, Exp 09/14